548 related articles for article (PubMed ID: 30170260)
21. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A
Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188
[TBL] [Abstract][Full Text] [Related]
22. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study.
Safarinejad MR
Andrologia; 2011 Feb; 43(1):38-47. PubMed ID: 21219381
[TBL] [Abstract][Full Text] [Related]
23. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
24. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.
Matsuoka Y; Nishi D; Hamazaki K; Yonemoto N; Matsumura K; Noguchi H; Hashimoto K; Hamazaki T
J Clin Psychiatry; 2015 Aug; 76(8):e1015-22. PubMed ID: 26335087
[TBL] [Abstract][Full Text] [Related]
25. A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study.
Wozniak J; Faraone SV; Chan J; Tarko L; Hernandez M; Davis J; Woodworth KY; Biederman J
J Clin Psychiatry; 2015 Nov; 76(11):1548-55. PubMed ID: 26646031
[TBL] [Abstract][Full Text] [Related]
26. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
[TBL] [Abstract][Full Text] [Related]
27. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial.
Flock MR; Skulas-Ray AC; Harris WS; Etherton TD; Fleming JA; Kris-Etherton PM
J Am Heart Assoc; 2013 Nov; 2(6):e000513. PubMed ID: 24252845
[TBL] [Abstract][Full Text] [Related]
28. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
29. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
30. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
Egert S; Somoza V; Kannenberg F; Fobker M; Krome K; Erbersdobler HF; Wahrburg U
Eur J Clin Nutr; 2007 Mar; 61(3):314-25. PubMed ID: 16969378
[TBL] [Abstract][Full Text] [Related]
31. 4-week eicosapentaenoic acid-rich fish oil supplementation partially protects muscular damage following eccentric contractions.
Tsuchiya Y; Ueda H; Yanagimoto K; Kato A; Ochi E
J Int Soc Sports Nutr; 2021 Mar; 18(1):18. PubMed ID: 33648546
[TBL] [Abstract][Full Text] [Related]
32. Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans.
Browning LM; Walker CG; Mander AP; West AL; Gambell J; Madden J; Calder PC; Jebb SA
J Nutr; 2014 May; 144(5):667-72. PubMed ID: 24647395
[TBL] [Abstract][Full Text] [Related]
33. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Hodson L; Moyses HE; Calder PC; Byrne CD;
Hepatology; 2014 Oct; 60(4):1211-21. PubMed ID: 25043514
[TBL] [Abstract][Full Text] [Related]
34. Omega-3 Supplementation and the Neural Correlates of Negative Affect and Impulsivity: A Double-Blind, Randomized, Placebo-Controlled Trial in Midlife Adults.
Ginty AT; Muldoon MF; Kuan DCH; Schirda B; Kamarck TW; Jennings JR; Manuck SB; Gianaros PJ
Psychosom Med; 2017 Jun; 79(5):549-556. PubMed ID: 28121722
[TBL] [Abstract][Full Text] [Related]
35. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans.
Ostermann AI; West AL; Schoenfeld K; Browning LM; Walker CG; Jebb SA; Calder PC; Schebb NH
Am J Clin Nutr; 2019 May; 109(5):1251-1263. PubMed ID: 31006007
[TBL] [Abstract][Full Text] [Related]
36. Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation.
Phang M; Sinclair AJ; Lincz LF; Garg ML
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):109-14. PubMed ID: 20708391
[TBL] [Abstract][Full Text] [Related]
37. Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients.
Daak AA; Ghebremeskel K; Mariniello K; Attallah B; Clough P; Elbashir MI
Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):305-11. PubMed ID: 24095588
[TBL] [Abstract][Full Text] [Related]
38. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
[TBL] [Abstract][Full Text] [Related]
39. Omega-3 fatty acids' effect on leptin and adiponectin concentrations in patients with spinal cord injury: A double-blinded randomized clinical trial.
Sabour H; Norouzi Javidan A; Latifi S; Shidfar F; Heshmat R; Emami Razavi SH; Vafa MR; Larijani B
J Spinal Cord Med; 2015 Sep; 38(5):599-606. PubMed ID: 25096818
[TBL] [Abstract][Full Text] [Related]
40. Very-long-chain
Hames KC; Morgan-Bathke M; Harteneck DA; Zhou L; Port JD; Lanza IR; Jensen MD
Am J Clin Nutr; 2017 Jun; 105(6):1552-1558. PubMed ID: 28424185
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
